Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 18 | 18 | 12 | 250 | 250 |
| Gross Profit | 18 | 18 | 12 | 250 | 250 |
| Operating Expenses | 35 | 390 | 447 | 439 | 467 |
| Operating Income | -16 | -346 | -460 | -189 | -217 |
| Interest Expense | 111 | 114 | 112 | 106 | 103 |
| Other Income | -171 | -26 | 26 | 0 | 1 |
| Pre-tax Income | -298 | -485 | -547 | -295 | -319 |
| Net Income Continuous | -298 | -485 | -547 | -295 | -319 |
| Net Income | $-298 | $-459 | $-572 | $-295 | $-319 |
| EPS Basic Total Ops | -50.00 | -100.00 | -100.00 | -50.00 | -50.00 |
| EPS Basic Continuous Ops | -48.61 | -79.11 | -89.20 | -48.13 | -52.11 |
| EPS Diluted Total Ops | -50.00 | -100.00 | -100.00 | -50.00 | -50.00 |
| EPS Diluted Continuous Ops | -48.61 | -79.11 | -89.20 | -48.13 | -52.11 |
| EBITDA(a) | $-15 | $-371 | $-435 | $-189 | $-217 |